EU flags AI-enabled designer drug synthesis outpacing enforcement
Source: Financial Times (paywall)
European drug trafficking organizations are using AI chemical modeling to engineer precursor compounds that circumvent existing regulatory blacklists faster than authorities can add them. The lag between innovation and regulatory response—typically months to years—has compressed to days or hours. Drug control frameworks depend on identifying dangerous substances post-hoc and blacklisting them. AI collapses that lag, rendering reactive regulation ineffective. Agencies built for regulatory timelines now face adversaries operating at algorithmic speed, raising a direct question: can prohibition regimes function when product iteration outpaces policy response.